Seeing Is Believing
Healthcare - Sector
TXG is currently covered by 12 analysts with an average price target of $42.95. This is a potential downside of $28.6 (-39.97%) from yesterday's end of day stock price of $71.55.
10X Genomics's activity chart (see below) currently has 191 price targets and 172 ratings on display. The stock rating distribution of TXG is 48.48% BUY and 51.52% HOLD.
Analysts average stock forecasts to be materialized ratio is 78.31% with an average time for these price targets to be met of 231.75 days.
Highest price target for TXG is $110, Lowest price target is $19, average price target is $42.95.
Most recent stock forecast was given by MASON CARRICO from STEPHENS.
Currently out of the existing stock ratings of TXG, 16 are a BUY (48.48%), 17 are a HOLD (51.52%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Jul-2022
$100
$28.45 (39.76%)
$60
12 days ago
(11-Oct-2026)
15/16 (93.75%)
$19.35 (23.99%)
293
Buy Since 23-Sep-2019
$110
$38.45 (53.74%)
$40
17 days ago
(06-Oct-2026)
16/17 (94.12%)
$33.9 (44.55%)
402
Hold Since 26-Jan-2026
$90
$18.45 (25.79%)
$40
25 days ago
(28-Sep-2026)
2/3 (66.67%)
$-0.04 (-0.04%)
331
Hold Since 10-Sep-2025
$80
$8.45 (11.81%)
$47
26 days ago
(27-Sep-2026)
5/6 (83.33%)
$-8.5 (-9.60%)
47
What is TXG (10X Genomics) average time for price targets to be met?
Which analyst most recently updated their price target on TXG (10X Genomics)?
Which analyst has the most public recommendations on TXG (10X Genomics)?
Which analyst is the currently most bullish on TXG (10X Genomics)?
Which analyst is the currently most reserved on TXG (10X Genomics)?